APX-2009

N/A

Report date: 2024/10/25 11:50:08
NME

Base Information

Drug NameAPX-2009
Drug Alias NameAPX2009APX-2009
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitorsDNA-(apurinic or apyrimidinic site) lyase inhibitors
TargetsDNA-(apurinic or apyrimidinic site) lyase
Therapy Area/IndicationsMacular DegenerationRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIndiana University School Of MedicineApexian Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOpus Genetics Inc
Inactive CompaniesN/A
Active IndicationsMacular DegenerationRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A